Evogene Ltd. Files Proxy Card for August 11 AGM
Ticker: EVGN · Form: 6-K · Filed: Jul 17, 2025 · CIK: 1574565
Sentiment: neutral
Topics: shareholder-meeting, proxy-card, filing-update
TL;DR
Evogene filed proxy materials for its Aug 11 shareholder meeting.
AI Summary
Evogene Ltd. filed a supplemental submission of a proxy card for its Annual General Meeting of Shareholders, scheduled for August 11, 2025. This filing follows a previous notice of the meeting and a Form 6-K filed on June 17, 2025. The company is based in Rehovot, Israel.
Why It Matters
This filing provides shareholders with the necessary proxy materials to vote at the upcoming Annual General Meeting, a crucial event for corporate governance and decision-making.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to an upcoming shareholder meeting.
Key Players & Entities
- Evogene Ltd. (company) — Registrant
- August 11, 2025 (date) — Annual General Meeting date
- June 17, 2025 (date) — Date of Original 6-K filing
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a supplemental submission of a proxy card for Evogene Ltd.'s Annual General Meeting of Shareholders.
When is the Annual General Meeting of Shareholders scheduled to be held?
The Annual General Meeting of Shareholders is scheduled to be held on August 11, 2025.
What was previously filed regarding the Annual General Meeting?
Evogene Ltd. previously published a notice of the annual general meeting and furnished a Report of Foreign Private Issuer on Form 6-K on June 17, 2025.
Where is Evogene Ltd. located?
Evogene Ltd.'s principal executive offices are located at 13 Gad Feinstein Street, Park Rehovot, Rehovot 7638517, Israel.
Under which form does Evogene Ltd. typically file its annual reports?
Evogene Ltd. files its annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 17, 2025 regarding Evogene Ltd. (EVGN).